Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran
Background and purpose: Several studies have shown the effectiveness of screening programs in decreasing the costs and disutility of type-2 diabetes and related complications. As there is a growth in the incidence of type-2 diabetes amongst the Iranian population, the cost-effectiveness of performin...
Saved in:
Main Authors: | Mohammadreza Amirsadri (Author), Elahe Torkpour (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness and cost-utility analysis of the use of clopidogrel and pantoprazole in comparison with clopidogrel and omeprazole for the secondary prevention of myocardial infarction in Iran
by: Mohammadreza Amirsadri, et al.
Published: (2021) -
Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis
by: Kari Jalkanen, et al.
Published: (2021) -
Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran
by: Mohammadreza Amirsadri, et al.
Published: (2017) -
Diabetes Screening Through Community Pharmacies in England: A Cost-Effectiveness Study
by: David Wright, et al.
Published: (2019) -
Neonatal Screening: Cost-utility Analysis for Galactosemia
by: Nahid HATAM, et al.
Published: (2017)